In 2021, Tianjin-based biopharmaceutical company, CanSino Biologics (CanSinoBIO) completed a Phase III clinical trial of their intramuscular COVID-19 vaccine, which involved 45,000 volunteers ...
Pierre A. Morgon, PharmD, LL.M, MBA, managing director at CanSino Biologics Europe, tells us about Convidecia, a single dose SARS-CoV-2 vaccine offered as an injectable and inhalant that allows ...
The Geneva-based World Health Organization (WHO) Thursday granted an emergency approval to the CONVIDECIA vaccine against COVID-19 developed by China's CanSino Biologics. The drug thus became the ...
Meanwhile, The Lancet also carries a 500-patient, phase 2 study from researchers in China on another adenoviral vector-based vaccine developed by CanSino Biologics, which also generated antibody ...
BEIJING--China’s vaccine specialist CanSino Biologics Inc. has won a patent approval from Beijing for its COVID-19 vaccine candidate Ad5-nCOV, state media reported, citing documents from the ...
KOTA BARU: The government will be supplying the CanSino vaccine to Kelantan in July to inoculate people living in the interior including Orang Asli. National Covid-19 Immunisation Programme ...
JAKARTA, Sept 7 (Reuters): Indonesia has approved the single-dose Covid-19 vaccines produced by Janssen Pharmaceutical Companies, part of Johnson & Johnson, and China's CanSino Biological Inc for ...
The Tianjin, China-based company, which was the first to move a vaccine into Phase II development, also became the first to published peer-reviewed data, from its Phase I study. Moderna released ...
Helping the momentum was CanSino Biologics (6185 HK) which gained +63.38% after the company reported more than a dozen cities have signed on for its inhalable COVID vaccine. The stock has gained ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback